Kestra Medical Technologies (KMTS) Payables (2024 - 2026)

Kestra Medical Technologies (KMTS) has 3 years of Payables data on file, last reported at $27.3 million in Q2 2026.

• On a quarterly basis, Payables rose 13.91% year-over-year to $27.3 million in Q2 2026; TTM through Apr 2026 was $27.3 million, a 13.91% increase from a year earlier, with the FY2026 full-year figure at $27.3 million, up 13.91% from the prior year.
• Payables for Q2 2026 stood at $27.3 million, up from $24.0 million in the prior quarter.
• Over the last five years, Payables for KMTS reached as high as $27.3 million in Q2 2026 and fell as low as $18.6 million in Q3 2025.
• Historically, Payables has averaged $23.4 million across 3 years, with a median of $24.0 million in 2025.
• On a YoY basis, Payables climbed as much as 13.91% in 2026 and fell as far as 6.37% in 2026.
• Year by year, Payables stood at $23.9 million in 2024, then dropped by 15.42% to $20.2 million in 2025, then jumped by 35.06% to $27.3 million in 2026.
• Per Business Quant data, the three most recent Payables figures were $27.3 million in Q2 2026, $24.0 million in Q1 2026, and $20.2 million in Q4 2025.